GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Qilian International Holding Group Ltd (NAS:QLI) » Definitions » Enterprise Value

Qilian International Holding Group (Qilian International Holding Group) Enterprise Value : $2.53 Mil (As of May. 21, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Qilian International Holding Group Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Qilian International Holding Group's Enterprise Value is $2.53 Mil. Qilian International Holding Group's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was $-2.42 Mil. Therefore, Qilian International Holding Group's EV-to-EBIT ratio for today is -1.04.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Qilian International Holding Group's Enterprise Value is $2.53 Mil. Qilian International Holding Group's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was $-1.28 Mil. Therefore, Qilian International Holding Group's EV-to-EBITDA ratio for today is -1.98.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Qilian International Holding Group's Enterprise Value is $2.53 Mil. Qilian International Holding Group's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was $46.47 Mil. Therefore, Qilian International Holding Group's EV-to-Revenue ratio for today is 0.05.


Qilian International Holding Group Enterprise Value Historical Data

The historical data trend for Qilian International Holding Group's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qilian International Holding Group Enterprise Value Chart

Qilian International Holding Group Annual Data
Trend Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Enterprise Value
Get a 7-Day Free Trial - - 143.80 31.90 7.86

Qilian International Holding Group Semi-Annual Data
Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 143.80 64.04 31.90 39.99 7.86

Competitive Comparison of Qilian International Holding Group's Enterprise Value

For the Drug Manufacturers - Specialty & Generic subindustry, Qilian International Holding Group's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Qilian International Holding Group's Enterprise Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Qilian International Holding Group's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Qilian International Holding Group's Enterprise Value falls into.



Qilian International Holding Group Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Qilian International Holding Group's Enterprise Value for the fiscal year that ended in Sep. 2023 is calculated as

Qilian International Holding Group's Enterprise Value for the quarter that ended in Sep. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Qilian International Holding Group  (NAS:QLI) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Qilian International Holding Group's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=2.526/-2.418
=-1.04

Qilian International Holding Group's current Enterprise Value is $2.53 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Qilian International Holding Group's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was $-2.42 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Qilian International Holding Group's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=2.526/-1.275
=-1.98

Qilian International Holding Group's current Enterprise Value is $2.53 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Qilian International Holding Group's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was $-1.28 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Qilian International Holding Group's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=2.526/46.472
=0.05

Qilian International Holding Group's current Enterprise Value is $2.53 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Qilian International Holding Group's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was $46.47 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Qilian International Holding Group Enterprise Value Related Terms

Thank you for viewing the detailed overview of Qilian International Holding Group's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Qilian International Holding Group (Qilian International Holding Group) Business Description

Traded in Other Exchanges
N/A
Address
Jiuquan Economic and Technological Development Zone, Gansu Province, Jiuquan, CHN, 735000
Qilian International Holding Group Ltd is a pharmaceutical and chemical company. The company is engaged in the development, manufacture, marketing, and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives products, heparin products, sausage casings, and fertilizers. It operates through three segments namely, Oxytetracycline and Licorice products and TCMD; Fertilizer; and Heparin products and Sausage casing. Oxytetracycline and Licorice products and TCMD segment generates majority of the revenue.

Qilian International Holding Group (Qilian International Holding Group) Headlines

From GuruFocus